Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Increased Levels of Serum Interleukin-17 in Patients with Hashimoto's Thyroiditis.

Esfahanian F, Ghelich R, Rashidian H, Jadali Z.

Indian J Endocrinol Metab. 2017 Jul-Aug;21(4):551-554. doi: 10.4103/ijem.IJEM_412_16.

2.

Serum macrophage migration inhibitory factor levels in Hashimoto's thyroiditis; a case control study.

Ayaz T, Sahin SB, Sahin OZ, Cure MC, Sumer F, Ilkkilic K.

Thyroid Res. 2014 Dec 5;7(1):11. doi: 10.1186/s13044-014-0011-1. eCollection 2014.

3.

The role of circulating sTWEAK in the pathogenesis of Hashimoto's thyroiditis - a pilot study.

Altay M, Ateş İ, Yılmaz FM, Topçuoğlu C, Kaplan M.

Endokrynol Pol. 2016;67(6):562-566. doi: 10.5603/EP.a2016.0033. Epub 2016 Feb 17.

4.

Circulating Th17 cytokine levels are altered in Hashimoto's thyroiditis.

Konca Degertekin C, Aktas Yilmaz B, Balos Toruner F, Kalkanci A, Turhan Iyidir O, Fidan I, Yesilyurt E, Cakır N, Kustimur S, Arslan M.

Cytokine. 2016 Apr;80:13-7. doi: 10.1016/j.cyto.2016.02.011. Epub 2016 Feb 27.

PMID:
26928603
5.

Role of interlekin-35 as a biomarker in patients with newly diagnosed Hashimoto's thyroiditis.

Yilmaz H, Cakmak M, Ceydilek B, Demir C, Aktas A.

Endocr Regul. 2016 Apr;50(2):55-61. doi: 10.1515/enr-2016-0009.

PMID:
27560637
6.

Influence of thyroxine on serum soluble interleukin-2 receptor alpha levels in thyroid disorders.

Zwirska-Korczala K, Berdowska A, Jochem J, Sitkiewicz A, Birkner E, Polaniak R, Jedrzejowska-Szypułka H, Korzonek-Szlacheta I.

J Clin Pharm Ther. 2004 Apr;29(2):151-6.

PMID:
15068404
7.

A higher frequency of circulating IL-22(+)CD4(+) T cells in Chinese patients with newly diagnosed Hashimoto's thyroiditis.

Guo H, Peng D, Yang XG, Wang Y, Xu BC, Ni JS, Meng W, Jiang YF.

PLoS One. 2014 Jan 3;9(1):e84545. doi: 10.1371/journal.pone.0084545. eCollection 2014.

8.

Increased serum concentration of interleukin-5 in patients with Graves' disease and Hashimoto's thyroiditis.

Hidaka Y, Okumura M, Shimaoka Y, Takeoka K, Tada H, Amino N.

Thyroid. 1998 Mar;8(3):235-9.

PMID:
9545110
9.

Immunological changes of T helper cells in flow cytometer-sorted CD4+ T cells from patients with Hashimoto's thyroiditis.

Guo Y, Zynat J, Xing S, Xin L, Li S, Mammat N, Chen Y, Zhao L, Zhao H, Wang X.

Exp Ther Med. 2018 Apr;15(4):3596-3602. doi: 10.3892/etm.2018.5825. Epub 2018 Feb 1.

10.

Serum concentrations of leptin, adiponectin, and interleukin-6 in postmenopausal women with Hashimoto's thyroiditis.

Siemińska L, Wojciechowska C, Kos-Kudła B, Marek B, Kajdaniuk D, Nowak M, Głogowska-Szelag J, Foltyn W, Strzelczyk J.

Endokrynol Pol. 2010 Jan-Feb;61(1):112-6.

11.

Serum interleukin-22 (IL-22) is increased in the early stage of Hashimoto's thyroiditis compared to non-autoimmune thyroid disease and healthy controls.

Ruggeri RM, Minciullo P, Saitta S, Giovinazzo S, Certo R, Campennì A, Trimarchi F, Gangemi S, Benvenga S.

Hormones (Athens). 2014 Jul-Sep;13(3):338-44. doi: 10.14310/horm.2002.1483.

12.

Down-regulation of the auto-aggressive processes in patients with hypothyroid Hashimoto's thyroiditis following substitutive treatment with L-thyroxine.

Guclu F, Ozmen B, Kirmaz C, Kafesciler SO, Degirmenci PB, Taneli F, Hekimsoy Z.

Eur Cytokine Netw. 2009 Mar;20(1):27-32. doi: 10.1684/ecn.2009.0147.

13.

Serum interleukin-23 (IL-23) is increased in Hashimoto's thyroiditis.

Ruggeri RM, Saitta S, Cristani M, Giovinazzo S, Tigano V, Trimarchi F, Benvenga S, Gangemi S.

Endocr J. 2014;61(4):359-63. Epub 2014 Jan 28.

14.

Different levels of circulating Th22 cell and its related molecules in Graves' disease and Hashimoto's thyroiditis.

Song RH, Yu ZY, Qin Q, Wang X, Muhali FS, Shi LF, Jiang WJ, Xiao L, Li DF, Zhang JA.

Int J Clin Exp Pathol. 2014 Jun 15;7(7):4024-31. eCollection 2014.

15.

Macrophage migration inhibitory factor interacting with Th17 cells may be involved in the pathogenesis of autoimmune damage in Hashimoto's thyroiditis.

Xue H, Yang Y, Zhang Y, Song S, Zhang L, Ma L, Yang T, Liu H.

Mediators Inflamm. 2015;2015:621072. doi: 10.1155/2015/621072. Epub 2015 Mar 15.

16.

Hashimoto's thyroiditis, but not treatment of hypothyroidism, is associated with altered TGF-beta1 levels.

Akinci B, Comlekci A, Yener S, Bayraktar F, Demir T, Ozcan MA, Yuksel F, Yesil S.

Arch Med Res. 2008 May;39(4):397-401. doi: 10.1016/j.arcmed.2007.12.001. Epub 2008 Feb 5.

PMID:
18375250
17.

Increased circulating pro-inflammatory cytokines and Th17 lymphocytes in Hashimoto's thyroiditis.

Figueroa-Vega N, Alfonso-Pérez M, Benedicto I, Sánchez-Madrid F, González-Amaro R, Marazuela M.

J Clin Endocrinol Metab. 2010 Feb;95(2):953-62. doi: 10.1210/jc.2009-1719. Epub 2009 Dec 16.

PMID:
20016049
18.

Increased proportions of Tc17 cells and NK cells may be risk factors for disease progression in Hashimoto's thyroiditis.

Liu Y, You R, Yu N, Gong Y, Qu C, Zhang Y, Lu G, Huang Y, Zhang H, Gao Y, Gao Y, Guo X.

Int Immunopharmacol. 2016 Nov;40:332-338. doi: 10.1016/j.intimp.2016.09.016. Epub 2016 Sep 23.

PMID:
27668571
19.

Relation of anti-TPO autoantibody titre and T-lymphocyte cytokine production patterns in Hashimoto's thyroiditis.

Karanikas G, Schuetz M, Wahl K, Paul M, Kontur S, Pietschmann P, Kletter K, Dudczak R, Willheim M.

Clin Endocrinol (Oxf). 2005 Aug;63(2):191-6.

PMID:
16060913
20.

Supplemental Content

Support Center